Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 16, 2021 08:00 ET | Source: Eyenovia, Inc.

Eyenovia to Host Key Opinion Leader Webinar on Presbyopia

NEW YORK, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Eyenovia, Inc., (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics,...
January 06, 2021 08:00 ET | Source: Eyenovia, Inc.

Eyenovia to Participate in Presbyopia Panel Discussion at the LifeSci Partners 10th Annual Corporate Access Event

NEW YORK, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Eyenovia, Inc., (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics,...
November 10, 2020 16:06 ET | Source: Eyenovia, Inc.

Eyenovia Reports Third Quarter 2020 Financial Results

NEW YORK, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc., (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics,...
November 05, 2020 08:00 ET | Source: Eyenovia, Inc.

Eyenovia to Report Third Quarter 2020 Results on Tuesday, November 10

NEW YORK, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc., (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics,...
October 13, 2020 07:00 ET | Source: Eyenovia, Inc.

Eyenovia to Host Investor Call to Discuss Recent Licensing Agreements Resulting in Total Potential License Payments and Development Cost Reimbursement and Savings of Approximately $100 Million

Company reaffirms near term milestones for the Mydcombi™ (MicroStat) NDA and the MicroLine presbyopia program Phase III results Call scheduled for today, Tuesday, October 13 at 4:30pm ET ...
September 09, 2020 08:30 ET | Source: Eyenovia, Inc.

Eyenovia to Present at the 22nd Annual H.C. Wainwright Global Investment Conference

NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics,...
August 24, 2020 08:30 ET | Source: Eyenovia, Inc.

Eyenovia, Inc. Announces Underwriters’ Full Exercise of Over-Allotment Option in Public Offering

NEW YORK, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics,...
August 21, 2020 16:05 ET | Source: Eyenovia, Inc.

Eyenovia, Inc. Announces Closing of Offering of Common Stock

NEW YORK, Aug. 21, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics,...
August 19, 2020 09:10 ET | Source: Eyenovia, Inc.

Eyenovia, Inc. Prices Public Offering of Common Stock

NEW YORK, Aug. 19, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics,...
August 18, 2020 16:03 ET | Source: Eyenovia, Inc.

Eyenovia, Inc. Announces Proposed Public Offering of Common Stock

NEW YORK, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics,...